What Happened?
Shares of fertility benefits company Progyny (NASDAQ: PGNY) jumped 17.5% in the afternoon session after the company reported first-quarter 2026 financial results that surpassed analyst expectations and raised its full-year guidance.
The fertility benefits provider announced adjusted earnings of $0.50 per share, easily beating the consensus estimate of $0.44. Revenue for the quarter grew 1.4% year-over-year to $328.5 million, which also topped Wall Street's expectations.
Looking ahead, the company provided an optimistic outlook, guiding for second-quarter revenue of $348.5 million at the midpoint, ahead of analyst forecasts. Furthermore, Progyny slightly raised its revenue guidance for the full year and issued an EBITDA forecast that was also above expectations, signaling confidence in its business momentum.
Is now the time to buy Progyny? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Progyny’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. But moves this big are rare even for Progyny and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 2 months ago when the stock dropped 22% on the news that it issued a weak financial outlook for 2026 that overshadowed its fourth-quarter results.
The company's guidance for the first quarter of 2026 projected revenue of $325.5 million, falling 5.1% short of Wall Street's expectations. Furthermore, the full-year forecast for 2026 was also disappointing, with both its adjusted earnings per share and EBITDA guidance missing analyst estimates.
This downbeat forecast soured investor sentiment despite Progyny reporting strong fourth-quarter 2025 results. For that period, the company's revenue of $318.4 million grew 6.7% year-over-year and beat expectations, while its adjusted earnings per share of $0.48 came in nearly 20% ahead of consensus estimates. Ultimately, the market focused on the weaker-than-expected projections, signaling concerns about future growth.
Progyny is down 12.8% since the beginning of the year, and at $22.43 per share, it is trading 21.1% below its 52-week high of $28.42 from January 2026. Investors who bought $1,000 worth of Progyny’s shares 5 years ago would now be looking at only $440.31.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
